The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis. (2023)
Attributed to:
New high resolution mass spectrometry facilities for macromolecules and metabolites at the University of East Anglia
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bcp.2023.115921
PubMed Identifier: 37956893
Publication URI: http://europepmc.org/abstract/MED/37956893
Type: Journal Article/Review
Volume: 218
Parent Publication: Biochemical pharmacology
ISSN: 0006-2952